WALPARPharmaceuticals
WALPAR NUTRITIONS — Cash Flow Statement
₹45.50
+0.00%
WALPAR NUTRITIONS Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | 3.48 Cr | -4.47 Cr | -4.93 Cr | -2.18 Cr |
| Issuance Of Capital Stock | 0.91 Cr | 0.00 | 5.84 Cr | 1.71 Cr |
| Capital Expenditure | -1.87 Cr | -5.57 Cr | -3.84 Cr | -1.86 Cr |
| End Cash Position | 0.51 Cr | 0.54 Cr | 0.46 Cr | 0.98 Cr |
| Other Cash Adjustment Outside Changein Cash | 1000.00 | 1000.00 | 1000.00 | -1000.00 |
| Beginning Cash Position | 0.54 Cr | 0.46 Cr | 0.98 Cr | 0.35 Cr |
| Changes In Cash | -0.03 Cr | 0.07 Cr | -0.51 Cr | 0.62 Cr |
| Financing Cash Flow | -1.77 Cr | 2.42 Cr | 6.71 Cr | 2.95 Cr |
| Net Other Financing Charges | -0.02 Cr | 0.17 Cr | 1.60 Cr | 0.03 Cr |
| Interest Paid Cff | -0.67 Cr | -0.79 Cr | -0.48 Cr | -0.18 Cr |
| Net Common Stock Issuance | 0.91 Cr | 0.00 | 5.84 Cr | 1.71 Cr |
| Common Stock Issuance | 0.91 Cr | 0.00 | 5.84 Cr | 1.71 Cr |
| Net Issuance Payments Of Debt | -2.00 Cr | 3.04 Cr | -0.24 Cr | 1.39 Cr |
| Net Short Term Debt Issuance | 0.04 Cr | -1.43 Cr | 2.77 Cr | 0.81 Cr |
| Net Long Term Debt Issuance | -2.04 Cr | 4.47 Cr | -3.01 Cr | 0.59 Cr |
| Investing Cash Flow | -3.61 Cr | -3.44 Cr | -6.14 Cr | -2.02 Cr |
| Net Other Investing Changes | 0.13 Cr | 31000.00 | -0.16 Cr | -0.15 Cr |
| Net Investment Purchase And Sale | -1.87 Cr | 0.47 Cr | -0.48 Cr | 0.00 |
| Net Intangibles Purchase And Sale | 0.00 | -0.33 Cr | — | — |
| Purchase Of Intangibles | 0.00 | -0.33 Cr | — | — |
| Net PPE Purchase And Sale | -1.87 Cr | -5.24 Cr | -3.84 Cr | -1.86 Cr |
| Purchase Of PPE | -1.87 Cr | -5.24 Cr | -3.84 Cr | -1.86 Cr |
| Operating Cash Flow | 5.35 Cr | 1.10 Cr | -1.08 Cr | -0.31 Cr |
| Taxes Refund Paid | -0.17 Cr | -0.08 Cr | -0.07 Cr | 0.00 |
| Change In Working Capital | 0.62 Cr | -2.62 Cr | -2.05 Cr | -0.77 Cr |
| Change In Other Current Liabilities | 1.25 Cr | 0.33 Cr | 0.09 Cr | 0.23 Cr |
| Change In Other Current Assets | 0.62 Cr | -0.20 Cr | -0.63 Cr | -0.04 Cr |
| Change In Payable | 0.45 Cr | 1.74 Cr | 2.42 Cr | 0.29 Cr |
| Change In Inventory | -0.66 Cr | -2.57 Cr | -1.60 Cr | -0.50 Cr |
| Change In Receivables | -1.04 Cr | -1.93 Cr | -2.32 Cr | -0.75 Cr |
| Other Non Cash Items | 0.66 Cr | 0.78 Cr | 0.48 Cr | 0.18 Cr |
| Depreciation And Amortization | 1.81 Cr | 1.91 Cr | 0.28 Cr | 0.12 Cr |
| Depreciation | 1.81 Cr | 1.91 Cr | 0.28 Cr | 0.11 Cr |
| Gain Loss On Investment Securities | -0.05 Cr | -68000.00 | -0.01 Cr | — |
| Gain Loss On Sale Of PPE | -0.01 Cr | 0.00 | — | — |
| Net Income From Continuing Operations | 2.49 Cr | 1.11 Cr | 0.27 Cr | 0.16 Cr |
| Sale Of Investment | — | 0.47 Cr | — | — |
| Interest Received Cfi | — | — | 0.01 Cr | 0.00 |
| Purchase Of Investment | — | — | -0.48 Cr | 0.00 |
| Amortization Cash Flow | — | — | 0.02 Cr | 61000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on WALPAR NUTRITIONS
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.